# INTRA-CELLULAR THERAPIES INC COMMON STOCK

INTRA-CELLULAR THERAPIES INC COMMON STOCK is a security (CUSIP 46116X101) tracked across SEC portfolio filings. 1 institutional managers reported $3K on Form 13F as of 2026-03-31; 2 registered fund positions totaling $7.5M via N-PORT as of 2023-12-31.

## Summary

- Issuer: INTRA-CELLULAR THERAPIES INC
- Class: COMMON STOCK
- CUSIP: 46116X101
- Asset category: EC
- 13F holders: 1
- 13F value: $3K
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $7.5M
- N-PORT report: 2023-12-31

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| HUNTINGTON NATIONAL BANK | COLUMBUS, OH | $3K | 1 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [HARTFORD SMALL CAP GROWTH HLS FUND](https://search.stillhousedata.com/fund/S000004108) | HARTFORD HLS SERIES FUND II INC | $7.4M | 96.96% |
| Weiss Strategic Interval Fund | Weiss Strategic Interval Fund | $26K | 0.51% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/46116X101.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.